BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6224723)

  • 1. A simple rapid method for the purification of D and E fragments of fibrinogen degradation by plasmin.
    Carvajal Z; Arocha-Pinango CL
    Haematologica; 1983; 68(3):336-40. PubMed ID: 6224723
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive exposure of E-neoantigen associated with degradation of crosslinked fibrin by plasmin in vitro.
    Stegnar M; Chen JP
    Thromb Haemost; 1984 Dec; 52(3):315-20. PubMed ID: 6241755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
    Carroll RC; Lockhart MS; Taylor FB
    J Lab Clin Med; 1984 May; 103(5):695-703. PubMed ID: 6232329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure.
    Francis CW; Marder VJ; Barlow GH
    J Clin Invest; 1980 Nov; 66(5):1033-43. PubMed ID: 6448866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionation of plasmic fibrinogen digest on lysine-agarose. Isolation of two fragments D, fragment E and simultaneous removal of plasmin.
    Rupp C; Sievi R; Furlan M
    Thromb Res; 1982 Jul; 27(1):117-21. PubMed ID: 6214865
    [No Abstract]   [Full Text] [Related]  

  • 6. A simple and practical method for isolation of an early plasmin degradation product of human fibrinogen.
    Takagi K; Kawai T
    Thromb Haemost; 1977 Jun; 37(3):464-70. PubMed ID: 142313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile purification of fibrinogen fragments using a computer-based model with general applicability to the generation of salt gradients.
    Olman MA; Williams WF; Strickland JH; Hagood JS; Simmons WL; Rivera KE
    Protein Expr Purif; 1998 Oct; 14(1):71-8. PubMed ID: 9758753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of fragments E and D on the plasmin hydrolysis of the fibrin clot].
    Lezhen TI; Kudinov SA
    Biokhimiia; 1986 Jun; 51(6):967-9. PubMed ID: 2942191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of human fibrinogen by plasmin: isolation and partial characterization of an early degradation product.
    Regañon E; Aznar J; Vila V
    Haemostasis; 1978; 7(1):26-34. PubMed ID: 147811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay of an early plasmin degradation product of human fibrinogen, "fragment A", and its clinical application.
    Takagi K; Kawai T
    Thromb Haemost; 1978 Feb; 39(1):1-11. PubMed ID: 148116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of isolated fibrinogen degradation products in laboratory diagnosis].
    Fedorova ZD; Paradeeva IK; Zhukova IV; Elizarova AI; Pshenichnaia LP
    Probl Gematol Pereliv Krovi; 1979 May; 24(5):54-6. PubMed ID: 450898
    [No Abstract]   [Full Text] [Related]  

  • 12. Degradation of human fibrinogen by plasmin: a kinetic study.
    Regañon E; Aznar J; Vila V
    Thromb Res; 1977 Mar; 10(3):411-9. PubMed ID: 140473
    [No Abstract]   [Full Text] [Related]  

  • 13. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of vasoactive peptides from human fibrin and fibrinogen degraded by plasmin.
    Belew M; Gerdin B; Porath J; Saldeen T
    Thromb Res; 1978 Dec; 13(6):983-94. PubMed ID: 155325
    [No Abstract]   [Full Text] [Related]  

  • 15. [The antiplasmin activity of the E fragments of fibrin and fibrinogen].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1990; (4):511-8. PubMed ID: 2148755
    [No Abstract]   [Full Text] [Related]  

  • 16. Affinity chromatography of fibrinogen plasminolysis fragment D.
    Hörmann H; Henschen A
    Thromb Haemost; 1979 Jun; 41(4):691-4. PubMed ID: 158232
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation and characterization of NH2-terminal fibrinogen B beta fragments from N-DSK of human fibrinogen.
    Birken S; Agosto G; Lahiri B; Canfield R
    Thromb Haemost; 1984 Feb; 51(1):16-21. PubMed ID: 6232727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior of fibrinogen fragments D and E in gel filtration experiments.
    Mihalyi E; Towne DW
    Thromb Res; 1976 Jan; 8(1):1-15. PubMed ID: 129881
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrin degradation products. A review of structures found in vitro and in vivo.
    Gaffney PJ
    Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocytic cell adhesion to intact and plasmin-modified fibrinogen: possible involvement of Mac-1 (CD11b/CD18) and ICAM-1 (CD54).
    Arefieva TL; Krasnikova TL
    J Cell Physiol; 2001 Sep; 188(3):403-9. PubMed ID: 11473367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.